OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
DYNE.PSX55

Dynea Pakistan Ltd

Commodity ChemicalsVerified

Dynea Pakistan Ltd maintains a strong liquidity position, with a current ratio of 2.85, indicating the company can cover its short-term liabilities more than two and a half times over. The company's liquidity is further supported by a low debt-to-equity ratio of 0.01, suggesting minimal reliance on debt financing and a conservative capital structure. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints if short-term obligations increase. In terms of profitability, Dynea Pakistan Ltd reports a return on equity (ROE) of 7.41% and a return on assets (ROA) of 5.16%, both of which are below the typical thresholds for high-performing firms in the commodity chemicals industry. These figures suggest that the company is generating returns, but not at a level that would be considered exceptional within its sector. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks, particularly in the volatile commodity chemicals industry. Dynea Pakistan Ltd's growth trajectory appears modest, with no specific revenue growth projections provided in the outlook. The company's capital expenditures for the period were negative at -99.21 million PKR, indicating a reduction in investment in long-term assets. This may suggest a strategic shift or a focus on cost optimization rather than expansion. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's low dilution risk is supported by the absence of significant share issuance activity and a stable number of shares outstanding, both basic and diluted, at 18.87 million. However, the negative net cash position after debt subtraction remains a concern for liquidity risk. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial statements and disclosures are consistent with its historical performance, with no significant deviations or new strategic initiatives reported.

30-day price · DYNE.PSX+39.00 (+14.4%)
Low$260.54High$330.00Close$309.00As of15 May, 00:00 UTC
Profile
CompanyDynea Pakistan Ltd
TickerDYNE.PSX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Dynea Pakistan Ltd is a chemical manufacturing company operating in the commodity chemicals sector, primarily generating revenue through the production and sale of chemical products.

Classification. Dynea Pakistan Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Dynea Pakistan Ltd maintains a strong liquidity position, with a current ratio of 2.85, indicating the company can cover its short-term liabilities more than two and a half times over. The company's liquidity is further supported by a low debt-to-equity ratio of 0.01, suggesting minimal reliance on debt financing and a conservative capital structure. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints if short-term obligations increase. In terms of profitability, Dynea Pakistan Ltd reports a return on equity (ROE) of 7.41% and a return on assets (ROA) of 5.16%, both of which are below the typical thresholds for high-performing firms in the commodity chemicals industry. These figures suggest that the company is generating returns, but not at a level that would be considered exceptional within its sector. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks, particularly in the volatile commodity chemicals industry. Dynea Pakistan Ltd's growth trajectory appears modest, with no specific revenue growth projections provided in the outlook. The company's capital expenditures for the period were negative at -99.21 million PKR, indicating a reduction in investment in long-term assets. This may suggest a strategic shift or a focus on cost optimization rather than expansion. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's low dilution risk is supported by the absence of significant share issuance activity and a stable number of shares outstanding, both basic and diluted, at 18.87 million. However, the negative net cash position after debt subtraction remains a concern for liquidity risk. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial statements and disclosures are consistent with its historical performance, with no significant deviations or new strategic initiatives reported.
Key takeaways
  • Dynea Pakistan Ltd maintains a conservative capital structure with a low debt-to-equity ratio of 0.01.
  • The company's ROE of 7.41% and ROA of 5.16% indicate moderate profitability but below industry-leading levels.
  • The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • Capital expenditures were negative at -99.21 million PKR, suggesting a focus on cost optimization rather than expansion.
  • The company faces medium liquidity risk due to a negative net cash position after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyPKR
Revenue$3.45B
Gross profit$752.1M
Operating income$529.5M
Net income$309.5M
R&D
SG&A
D&A
SBC
Operating cash flow$398.4M
CapEx-$99.2M
Free cash flow$209.9M
Total assets$5.99B
Total liabilities$1.82B
Total equity$4.18B
Cash & equivalents
Long-term debt$62.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$6.83B$1.45B$938.6M$578.2M
FY-3$9.54B$1.19B$621.5M$346.5M
FY-2$11.08B$1.42B$665.2M$518.4M
FY-1$12.76B$2.11B$1.19B$836.3M
FY0$12.73B$1.59B$867.7M$507.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$3.41B$2.38B
FY-3$3.91B$2.91B
FY-2$4.56B$3.43B
FY-1$5.55B$4.29B
FY0$6.31B$4.88B
PeriodOCFCapExFCFSBC
FY-4$652.4M-$329.9M$578.2M
FY-3$300.8M-$345.7M$346.5M
FY-2$984.7M-$259.3M$518.4M
FY-1$762.3M-$200.5M$836.3M
FY0$1.24B-$310.7M$507.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$3.45B$529.5M$309.5M$209.9M
FQ-6$2.48B$214.2M$116.9M-$25.7M
FQ-5$2.87B$292.9M$151.8M$147.5M
FQ-4$3.60B$532.6M$296.6M$128.1M
FQ-3$3.27B$440.4M$242.7M$183.6M
FQ-2$3.00B$325.6M$176.6M$47.9M
FQ-1$3.33B$354.7M$191.2M$198.8M
FQ0$3.88B$645.4M$362.2M$116.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$5.99B$4.18B
FQ-6$5.55B$4.29B
FQ-5$5.58B$4.45B
FQ-4$6.31B$4.55B
FQ-3$6.20B$4.70B
FQ-2$6.31B$4.88B
FQ-1$6.57B$5.07B
FQ0$7.42B$5.24B
PeriodOCFCapExFCFSBC
FQ-7$398.4M-$99.2M$209.9M
FQ-6$762.3M-$200.5M-$25.7M
FQ-5$25.0M-$60.6M$147.5M
FQ-4$273.7M-$99.7M$128.1M
FQ-3$363.8M-$148.9M$183.6M
FQ-2$1.24B-$310.7M$47.9M
FQ-1$62.4M-$49.7M$198.8M
FQ0-$52.8M-$167.4M$116.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.18B
Net cash-$62.3M
Current ratio2.9
Debt/Equity0.0
ROA5.2%
ROE7.4%
Cash conversion1.3%
CapEx/Revenue-2.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricDYNE.PSXActivity
Op margin15.4%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin9.0%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin21.8%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-2.9%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity1.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 05:24 UTC#bc794e40
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 19:43 UTCJob: dc742f5e